Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, The Fly reports. They currently have $85.00 target price on the medical research company’s stock, up from their prior target price of $55.00. Other analysts have […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective increased by Bank of America from $80.00 to $88.00 in a research note published on Wednesday, The Fly reports. EXAS has been the subject of several other reports. Raymond James downgraded shares of Exact Sciences from an outperform rating to a market perform rating in […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price hoisted by equities research analysts at Citigroup from $90.00 to $100.00 in a report issued on Thursday, The Fly reports. Citigroup’s target price would suggest a potential upside of 27.02% from the company’s previous close. Several other brokerages have also weighed in on EXAS. StockNews.com […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target increased by Stifel Nicolaus from $75.00 to $85.00 in a research note published on Wednesday, The Fly reports. Several other brokerages also recently weighed in on EXAS. Piper Sandler increased their price target on Exact Sciences from $50.00 to $70.00 and gave the stock a […]
Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research report released on Wednesday morning, The Fly reports. The firm currently has $85.00 price objective on the medical research company’s stock, up from their previous price objective of $55.00. Other equities research analysts […]